Identification of potential core genes in triple negative breast cancer using bioinformatics analysis

Man-Xiu Li1, Li-Ting Jin1, Tie-Jun Wang1

  • 1Department of Breast Cancer, Hubei Cancer Hospital, Wuhan, People's Republic of China, 39390822@qq.com.

Oncotargets and Therapy
|August 25, 2018
PubMed
Abstract

Insights

Triple-negative breast cancer (TNBC) has limited treatment options. This study identified CCNB1 as a potential therapeutic target, showing its overexpression is linked to poor outcomes in TNBC patients.

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • Triple-negative breast cancer (TNBC) presents a significant clinical challenge due to its aggressive nature and limited targeted therapies.
  • Current treatment for TNBC primarily relies on chemotherapy, highlighting the urgent need for novel therapeutic strategies.
  • Identifying specific molecular targets is crucial for improving TNBC patient outcomes.

Purpose of the Study:

  • To identify potential therapeutic targets for triple-negative breast cancer.
  • To analyze gene expression profiles and identify differentially expressed genes (DEGs) in TNBC.
  • To evaluate the prognostic significance of identified genes in breast cancer.

Main Methods:

  • Analysis of three Gene Expression Omnibus (GEO) microarray datasets (GSE38959, GSE45827, GSE65194) using GEO2R.
  • Functional and pathway enrichment analysis of DEGs via DAVID.
  • Protein-protein interaction network construction using STRING and visualized with Cytoscape.
  • Prognostic value assessment using the Kaplan-Meier plotter.

Main Results:

  • Identification of 278 upregulated and 173 downregulated DEGs between TNBC and normal tissues.
  • Ten hub genes with high connectivity were identified from the DEG analysis.
  • Overexpression of these hub genes, particularly CCNB1, was significantly associated with unfavorable prognosis in breast cancer patients, especially in TNBC.

Conclusions:

  • CCNB1 is significantly overexpressed in triple-negative breast cancer compared to normal breast tissue.
  • Overexpression of CCNB1 serves as an unfavorable prognostic factor for TNBC patients.
  • CCNB1 warrants further investigation as a potential therapeutic target for TNBC treatment.

Related Concept Videos

The Nucleosome Core Particle02:10

The Nucleosome Core Particle

Nucleosomes are the DNA-histone complex, where the DNA strand is wound around the histone core. The histone core is an octamer containing two copies of H2A, H2B, H3, and H4 histone proteins.
The paradox
Nucleosomes, paradoxically, perform two opposite functions simultaneously. On the one hand, their main responsibility is to protect the delicate DNA strands from physical damage and help achieve a higher compaction ratio. While on the other hand, they must allow polymerase enzymes to access DNA...
14.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.5K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
768
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K
Scalar and Vector Triple Products01:06

Scalar and Vector Triple Products

Two vectors can be multiplied using a scalar product or a vector product. The resultant of a scalar product is scalar, while with vector products, the resultant is a vector. These rules of the scalar or vector product between two vectors can be applied to multiple vectors to obtain meaningful combinations. The scalar triple product is the dot product of a vector with the cross product of two vectors.
The scalar triple product is the dot product of a vector with the cross product of two vectors....
4.5K